Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Time to insulin initiation after escalating to semaglutide 2.0 mg versus switching to tirzepatide among adults with type 2 diabetes receiving semaglutide 1.0 mg
Gang Fang1; Chalak Muhammad1; Caroline Swift1; Josh Noone1; Michael Liang1; Sherif Mehanna1; Prachi Priyadashini2; Kathryn Tierney3
MATERIALS AVAILABLE
Coming soon
12:00 - 13:00
EDT
Add to calendar
POSTER
Real-World Glycemic Control With High-Dose Once-Weekly Semaglutide 2 mg in Adults With Type 2 Diabetes